NASDAQ: BNTCRUSSELL2000

Benitec Biopharma Inc.

Healthcare · Biotechnology · Headquartered in Hayward, US

Price

Loading chart…

Overview

Benitec Biopharma Inc. is an emerging biotechnology firm dedicated to advancing groundbreaking genetic medicines. The company specializes in DNA-directed RNA interference (RNAi) based treatments, which it develops to address severe and enduring human conditions. Its pipeline features BB-301, an adeno-associated virus (AAV) gene therapy aimed at treating oculopharyngeal muscular dystrophy, and BB-103, designed to combat chronic hepatitis B virus infection. Established in 1995, Benitec Biopharma's main operations are situated in Hayward, California.

History & business model

This section is waiting to be written.

InvestWiki is community-edited. Contribute a plain-English history of Benitec Biopharma Inc., its business model, key products, and controversies.

Write this articleSign in required. Edits go to moderator review.View history →